|
Liver carcinoma
|
0.600 |
Biomarker
|
disease |
RGD |
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
|
17196522 |
2007 |
|
Epithelial ovarian cancer
|
0.240 |
Biomarker
|
disease |
RGD |
Overexpression of p21, cyclin E and decreased expression of p27 in DMBA (7, 12-dimethylbenzanthracene)-induced rat ovarian carcinogenesis.
|
12713563 |
2003 |
|
Liver neoplasms
|
0.220 |
Biomarker
|
group |
RGD |
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
|
17196522 |
2007 |
|
Malignant neoplasm of liver
|
0.220 |
Biomarker
|
disease |
RGD |
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
|
17196522 |
2007 |
|
Colonic Neoplasms
|
0.200 |
Biomarker
|
group |
RGD |
Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
|
14614307 |
2000 |
|
Diabetic Nephropathy
|
0.200 |
Biomarker
|
disease |
RGD |
Growth pattern switch of renal cells and expression of cell cycle related proteins at the early stage of diabetic nephropathy.
|
17825795 |
2007 |
|
Hypertensive disease
|
0.200 |
Biomarker
|
group |
RGD |
Different cell cycle regulation of vascular smooth muscle in genetic hypertension.
|
12847112 |
2003 |
|
Mammary Neoplasms, Experimental
|
0.200 |
Biomarker
|
phenotype |
RGD |
Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors.
|
12602925 |
2003 |
|
Mammary Neoplasms, Experimental
|
0.200 |
Biomarker
|
phenotype |
RGD |
Effect of energy restriction on cell cycle machinery in 1-methyl-1-nitrosourea-induced mammary carcinomas in rats.
|
12649181 |
2003 |
|
Reperfusion Injury
|
0.200 |
Biomarker
|
disease |
RGD |
Impaired hepatic regeneration by ischemic preconditioning in a rat model of small-for-size liver transplantation.
|
17584601 |
2007 |
|
Hepatoblastoma
|
0.200 |
Biomarker
|
disease |
RGD |
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
|
17196522 |
2007 |
|
Hepatoblastoma Caused By Somatic Mutation
|
0.200 |
Biomarker
|
disease |
RGD |
Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
|
17196522 |
2007 |
|
Liver carcinoma
|
0.600 |
Biomarker
|
disease |
LHGDN |
Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
|
12601350 |
2003 |
|
Mammary Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
|
16912169 |
2006 |
|
Mammary Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
|
15665273 |
2005 |
|
Mammary Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
|
12096344 |
2002 |
|
Mammary Neoplasms
|
0.370 |
AlteredExpression
|
group |
LHGDN |
Cyclin E expression in breast cancer correlates with negative steroid receptor status, HER2 expression, tumor grade and proliferation.
|
16761619 |
2006 |
|
Mammary Neoplasms
|
0.370 |
Biomarker
|
group |
LHGDN |
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
|
16740753 |
2006 |
|
Mammary Neoplasms
|
0.370 |
Biomarker
|
group |
LHGDN |
Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
|
12444551 |
2002 |
|
Glioma
|
0.050 |
AlteredExpression
|
disease |
LHGDN |
Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.
|
12778072 |
2003 |
|
Adenocarcinoma
|
0.040 |
Biomarker
|
group |
LHGDN |
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.
|
17360482 |
2007 |
|
Squamous cell carcinoma
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
|
14719078 |
2004 |
|
leukemia
|
0.020 |
Biomarker
|
disease |
LHGDN |
[The significance of cyclin E expression and cyclin E-dependent kinase inhibitor in adult acute leukemia].
|
12133429 |
2002 |
|
leukemia
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.
|
16538501 |
2006 |
|
Fibrosis
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
|
12601350 |
2003 |